131 related articles for article (PubMed ID: 15360012)
1. Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab.
Morgensztern D; Rosado MF; Serafini AN; Lossos IS
Leuk Lymphoma; 2004 Jun; 45(6):1275-8. PubMed ID: 15360012
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
Raderer M; Traub T; Formanek M; Virgolini I; Osterreicher C; Fiebiger W; Penz M; Jäger U; Pont J; Chott A; Kurtaran A
Br J Cancer; 2001 Nov; 85(10):1462-6. PubMed ID: 11720429
[TBL] [Abstract][Full Text] [Related]
3. Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
Mayerhoefer ME; Karanikas G; Kletter K; Kiesewetter B; Weber M; Rausch I; Pones M; Simonitsch-Klupp I; Müllauer L; Dolak W; Lukas J; Raderer M
Clin Nucl Med; 2016 Nov; 41(11):837-843. PubMed ID: 27648705
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland.
Heinz C; Merz H; Nieschalk M; Mueller-Miny H; Koch P; Heiligenhaus A
Br J Ophthalmol; 2007 Nov; 91(11):1563-4. PubMed ID: 17947275
[No Abstract] [Full Text] [Related]
5. MALT lymphoma of the lacrimal gland in the context of systemic lupus erythematosus: complete remission after treatment with rituximab.
Tektonidou MG
Lupus; 2010 Sep; 19(10):1243-5. PubMed ID: 20501524
[TBL] [Abstract][Full Text] [Related]
6. PET/CT findings in a case with FDG-avid disseminated lacrimal gland MALToma with sequential development of large B-cell lymphoma and gastric MALToma.
Yildirim-Poyraz N; Ozdemir E; Basturk A; Kilicarslan A; Turkolmez S
Clin Nucl Med; 2015 Feb; 40(2):141-5. PubMed ID: 24873799
[TBL] [Abstract][Full Text] [Related]
7. 111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.
Li S; Kurtaran A; Li M; Traub-Weidinger T; Kienast O; Schima W; Angelberger P; Virgolini I; Raderer M; Dudczak R
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1087-95. PubMed ID: 12768334
[TBL] [Abstract][Full Text] [Related]
8. Favourable response to rituximab by an ocular adnexal primary lymphoma.
Luque Valentin-Fernandez ML; Alvarez Rodríguez F; Rodríguez Jiménez I
Arch Soc Esp Oftalmol; 2016 Nov; 91(11):539-542. PubMed ID: 27125186
[TBL] [Abstract][Full Text] [Related]
9. Systemically disseminated extranodal marginal zone B-cell lymphoma of lacrimal gland in a patient with systemic lupus erythematosus.
Lin YC; Kau HC; Kao SC; Hsu WM; Tsai CC
Ophthalmic Plast Reconstr Surg; 2007; 23(1):72-3. PubMed ID: 17237702
[TBL] [Abstract][Full Text] [Related]
10. [MALT (mucosa-associated lymphoid tissue) lymphoma of the lacrimal gland].
Roussel B; Bettembourg O; Cochard C; Cochener B
J Fr Ophtalmol; 2007 Nov; 30(9):961-5. PubMed ID: 18046283
[TBL] [Abstract][Full Text] [Related]
11. [Case of a bilateral MALT lymphoma of the lacrimal sac treated only medically].
Abdelkhalek R; Ahmimech J; Mouzariae Y; El Idrissi A; El Hamichi S; Messaoudi R; Bargach T; Reda K; Oubaaz A
J Fr Ophtalmol; 2015 Dec; 38(10):e237. PubMed ID: 26616299
[No Abstract] [Full Text] [Related]
12. Treatment of localized oral MALT lymphoma by rituximab: a case report.
Yamagata K; Onizawa K; Kojima H; Yoshida H
Oral Maxillofac Surg; 2008 Dec; 12(4):227-30. PubMed ID: 18830723
[TBL] [Abstract][Full Text] [Related]
13. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
Raderer M; Jäger G; Brugger S; Püspök A; Fiebiger W; Drach J; Wotherspoon A; Chott A
Oncology; 2003; 65(4):306-10. PubMed ID: 14707449
[TBL] [Abstract][Full Text] [Related]
14. Multifocal mucosa-associated lymphoid tissue lymphoma associated with IgG4-related disease: a case report.
Oyama T; Takizawa J; Nakamura N; Aoki S; Aizawa Y; Abe H
Jpn J Ophthalmol; 2011 May; 55(3):304-306. PubMed ID: 21584726
[No Abstract] [Full Text] [Related]
15. Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma.
Seker M; Bilici A; Ustaalioglu BO; Salman T; Sonmez B; Canpolat NA; Salepci T; Gumus M; Yaylaci M
Leuk Res; 2009 Sep; 33(9):e154-6. PubMed ID: 19386361
[No Abstract] [Full Text] [Related]
16. Somatostatin receptor imaging in intracranial tumours.
Schmidt M; Scheidhauer K; Luyken C; Voth E; Hildebrandt G; Klug N; Schicha H
Eur J Nucl Med; 1998 Jul; 25(7):675-86. PubMed ID: 9662588
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors.
Janson ET; Kälkner KM; Eriksson B; Westlin JE; Oberg K
Nucl Med Biol; 1999 Nov; 26(8):877-82. PubMed ID: 10708300
[TBL] [Abstract][Full Text] [Related]
18. Sarcoidosis in a clinically unaffected joint demonstrated by somatostatin receptor scintigraphy.
Kroot EJ; Dolhain RJ; van Hagen PM; Kwekkeboom DJ
Clin Nucl Med; 2006 Aug; 31(8):501-3. PubMed ID: 16855445
[No Abstract] [Full Text] [Related]
19. Rituximab-induced remission of a gastric MALT lymphoma.
Datta YH; Kampalath B; Binion DG
Leuk Lymphoma; 2004 Jun; 45(6):1297-9. PubMed ID: 15360017
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor scintigraphy in cutaneous malignant lymphomas.
van den Anker-Lugtenburg PJ; Heule F; Vanhagen PM; van Joost T; Oei HY; Löwenberg B; Krenning EP
J Am Acad Dermatol; 1996 Jun; 34(6):985-93. PubMed ID: 8647992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
